Press Release

Personnel Change of ASKA Pharmaceutical

TOKYO, March 27, 2023 - ASKA Pharmaceutical Holdings Co., Ltd. (Head Office: Minato-ku, Tokyo/ President, Representative Director: Takashi Yamaguchi) announced the following personnel change of its subsidiary, ASKA Pharmaceutical Co., Ltd., effective April 1, 2023.

1. Personnel Change

Tetsuya Yamamoto

[New Responsibilities]

Director of Iwaki General Affairs Department, Production Division [Current Responsibilities]

Manager of Tokyo Sales Office, East Japan Sales Department Region 1, Sales Division

Media Contacts

ASKA Pharmaceutical Holdings Co., Ltd. Corporate Planning Department

Tel: +81-3-5484-8366

Email:kouhou@aska-pharma.co.jp

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

ASKA Pharmaceutical Co. Ltd. published this content on 27 March 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 27 March 2023 07:57:07 UTC.